Desensitization to hydroxychloroquine-experience of 4 patients

Journal of Rheumatology

Volumn 33, Issue 4, 2006, Pages 814-816

  Mates, Michal ^a   Zevin, Shoshana ^a   Breuer, Gabriel S ^a   Navon, Pnina ^a   Nesher, Gideon ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Desensitization; Hydroxychloroquine; Hypersensitivity

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETORICOXIB; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; CASE REPORT; DESENSITIZATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; HYPERTENSION; JUVENILE RHEUMATOID ARTHRITIS; PRIORITY JOURNAL; RASH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIRHEUMATIC AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MIDDLE AGED; RHEUMATIC DISEASES;

EID: 33645815287     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brocks DR, Skeith KJ, Johnston C, et al. Hematologie disposition of hydroxychloroquine enantiomers. J Clin Pharmacol 1994;34:1088-97.
2. McLachlan AJ, Tett SE, Cutler DJ, Day RO. Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. Br J Clin Pharmacol 1993;36:78-81.
3. Fox RI. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Semin Arthritis Rheum 1993;23 Suppl 1:82-91.
4. Fox RI, Kang HI. Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation. Lupus 1993;2 Suppl I:S9-12.
5. van den Borne BE, Dijkmans BA, de Rooij HH, le Cessie S, Verweij CL. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol 1997;24:55-60.
6. Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood 2000;95:3460-6.
7. Jeong JY, Choi JW, Jeon KI, Jue DM. Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells. Immunology 2002;105:83-91.
8. Boya P, Gonzalez Polo RA, Poncet D, et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 2003;22:3927-36.
9. Fessler BJ, Alarcon GS, McGwin G, Jr, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 2005;52:1473-80.
10. The Canadian Hydroxychloroquine Study Group. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991;324:150-4.
11. Ruzicka T, Sommerburg C, Goerz G, Kind P, Mensing H. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 1992;127:513-8.
12. Williams HJ, Egger MJ, Singer JZ, et al. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J Rheumatol 1994;21:1457-62.
13. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. Arthritis Rheum 1990;33:1449-61.
14. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum 1992;35:1117-25.
15. Gordon AC, Klinkhoff AV. Second line agents. In: Koopman WJ, editor. Kelly's textbook of rheumatology, 7th ed. Lippincot, Williams and Wilkins: 2005:877-99.
16. Rynes RI. Antimalarial drugs in the treatment of rheumatic diseases. In: Rose BD, editor. Wellesley, MA: UpToDate; 2005.
17. Hippisley Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366.
18. Garai F, Montgomery RM. Further successful desensitization to penicillin. N Y State J Med. 1953;53:448.
19. Stevenson DD. Aspirin desensitization. N Engl Reg Allergy Proc 1986;7:101-4.
20. Nitti F, Fumagalli M, Incorvaia C. Rush desensitization to allopurinol. Allergy 2003;58:690.
21. Ostroukhova M, Ray A. CD25+ T cells and regulation of allergen-induced responses. Curr Allergy Asthma Rep 2005;5:35-41.
22. Gardner LM, Thien FC, Douglass JA, Rolland JM, O'Hchir RE. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers. Clin Exp Allergy 2004;34:1209-19.